Minims Phenylephrine 2,5 %, Minims Phenylephrine Hydrochloride 10 % 12,5 mg Eye drops,
PDF Leaflet Revision Date: 13 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Mydriatic for ophthalmic use.
Dosage (summary)
Use as directed by ophthalmologist; discard after use.
Onset of Action / Duration
Onset: 15 mins, Duration: ~5 hours
Special Populations
- Children under 12 years
- Elderly
- Patients with cardiac disease
Pregnancy & Breastfeeding
Safety not established during pregnancy and lactation.
Key Drug Interactions
- MAOIs
- Tricyclic antidepressants
- Anti-hypertensive medicines
Contraindications
- Hypersensitivity to phenylephrine
- Angle-closure glaucoma
- Severe hypertension
Common side effects
- Eye irritation
- Blurred vision
- Tachycardia
Counselling Points
- Discard after single use
- May impair vision temporarily
- Monitor for allergic reactions
Serious warnings
- Use with caution in cardiovascular disease
- Risk of serious systemic reactions
Important Disclaimer
The Minims Phenylephrine 2,5 %, Minims Phenylephrine Hydrochloride 10 % 12,5 mg Eye drops, professional information leaflet below is the property of Soflens and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
